Prof. Gil Dubernard, Head of the Gynecology Department at Croix-Rousse University Hospital, Lyon, France, will deliver a presentation at the 6th European Endometriosis Congress EDAP to Showcase its Focal One® Platform at the Annual Meeting of the American Urological Association (AUA) Company announces Focal One® placements at three renowned academic institutions in March Ryan Rhodes, new CEO of EDAP USA was featured in MDDI this week. Rhodes hales from Intuitive Surgical where he helped build the DaVinci Robot brand. He compares HIFU to the early days of robotic surgery: “The HIFU market is still in its infancy, and Rhodes said it reminds him of his early days at Intuitive Surgical, when the Irvine, CA-based robotics company was focused on prostate cancer, specifically radical prostatectomy, which was also a very young market at the time.”
Jun 14, 2022
EDAP holds a Symposium at 6th European Endometriosis Congress
May 5, 2022
EDAP to Showcase its Focal One® Platform at the Annual Meeting of the American Urological Association (AUA)
Apr 12, 2022
EDAP Provides Corporate Update on US Focal One® Installation Growth
Oct 7, 2021
Beyond Death Valley: Medtech Veteran Breathes New Life into HIFU Company
Sep 7, 2021
EDAP's HIFU Progress Is Obscured By The Pandemic, But It's Real
Very positive article on EDAP’s future and its advances on #HIFU, written by Seeking Alpha. Read more
Jun 15, 2021
EDAP Announces Hiring of MedTech Industry Veteran Ryan Rhodes as CEO of Company’s U.S. Subsidiary
LYON, France, June 15, 2021 -- EDAP TMS SA, the global leader in robotic energy-based therapies, announced today that the company has hired medical technology industry veteran Ryan Rhodes as Chief Executive Officer of EDAP Technomed, the Company’s U.S. subsidiary. Read more
May 9, 2021
In the C-Suite with Marc Oczachowski, CEO, EDAP TMS
We venture to Lyon, France to learn how Marc and his team fresh off a $28 million raise are setting the stage to dominate High Intensity Focused Ultrasound (HIFU) for prostate cancer. Read more
Mar 3, 2021
EDAP Selects Leading Reimbursement Consultancies MTP and Argenta Advisors to Expand Market Access and Coverage of HIFU in the US
EDAP TMS, the global leader in robotic energy-based therapies, announces today that the company has selected Medical Technology Partners (MTP) and Argenta Advisors, two leading reimbursement consultancies, to further expand coverage, accelerate market access and secure future payment rates for the company’s Focal One high intensity focused ultrasound (HIFU) procedure in the US. The announcement follows the establishment of a Category 1 CPT code, and physician reimbursement for HIFU, that went into effect on January 1, 2021. Read more
Feb 18, 2021
The Future Is Now: Marc Oczachowski of EDAP TMS On How Their Technological Innovation Will Shake Up Healthcare
Marc Oczachowski is Chairman of the Board and Chief Executive Officer of EDAP TMS, a high-tech medical company which develops, manufactures markets minimally invasive therapeutic ultrasound solutions for urology, tumor removal, localized prostate cancer, and infectious diseases. Read more
Jan 14, 2021
Positive 24 month interim results of French Urology Association (AFU) sponsored clinical trial study comparing HIFU to radical prostate surgery
Positive 24 month interim results of French Urology Association (AFU) sponsored clinical trial study comparing HIFU to radical prostate surgery: results on 3,329 patients demonstrate significant difference in efficacy in favor of HIFU versus Radical Prostatectomy (RP). Read more